Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Davison

Showing results (441-450 of 451) with videos related to

Pageof 46
Sort By:
Circulation. Heart Failure|November 1, 2023
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF RegistryMatteo Pagnesi, Daniele Ghiraldin, Enrico Vizzardi, et al.
JACC. Heart Failure|November 15, 2020
Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2Rahul S Loungani, John R Teerlink, Marco Metra, et al.
Lancet (London, England)|November 13, 2012
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialJohn R Teerlink, Gad Cotter, Beth A Davison, et al.
Journal of the American College of Cardiology|January 1, 2013
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomesMarco Metra, Gad Cotter, Beth A Davison, et al.
European Journal of Heart Failure|December 19, 2020
Is acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHFBeth A Davison, Stefanie Senger, Iziah E Sama, et al.
Drug Safety|February 21, 2012
The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECTJohn R Teerlink, Vicente J Iragui, Jay P Mohr, et al.
European Journal of Heart Failure|September 9, 2015
Signature of circulating microRNAs in patients with acute heart failureEkaterina S Ovchinnikova, Daniela Schmitter, Eline L Vegter, et al.
Open Forum Infectious Diseases|April 23, 2024
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across AustraliaDao Sen Wang, Amy Phu, Kristen McKee, et al.
Heart Failure Reviews|February 12, 2025
Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysisBeth A Davison, Antonio Abbate, Gad Cotter, et al.
The New England Journal of Medicine|August 22, 2019
Effects of Serelaxin in Patients with Acute Heart FailureMarco Metra, John R Teerlink, Gad Cotter, et al.
Pageof 46

Showing results (441-450 of 451) with videos related to

Sort By:
Pageof 46
Circulation. Heart Failure|November 1, 2023
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF RegistryMatteo Pagnesi, Daniele Ghiraldin, Enrico Vizzardi, et al.
JACC. Heart Failure|November 15, 2020
Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2Rahul S Loungani, John R Teerlink, Marco Metra, et al.
Lancet (London, England)|November 13, 2012
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialJohn R Teerlink, Gad Cotter, Beth A Davison, et al.
Journal of the American College of Cardiology|January 1, 2013
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomesMarco Metra, Gad Cotter, Beth A Davison, et al.
European Journal of Heart Failure|December 19, 2020
Is acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHFBeth A Davison, Stefanie Senger, Iziah E Sama, et al.
Drug Safety|February 21, 2012
The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECTJohn R Teerlink, Vicente J Iragui, Jay P Mohr, et al.
European Journal of Heart Failure|September 9, 2015
Signature of circulating microRNAs in patients with acute heart failureEkaterina S Ovchinnikova, Daniela Schmitter, Eline L Vegter, et al.
Open Forum Infectious Diseases|April 23, 2024
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across AustraliaDao Sen Wang, Amy Phu, Kristen McKee, et al.
Heart Failure Reviews|February 12, 2025
Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysisBeth A Davison, Antonio Abbate, Gad Cotter, et al.
The New England Journal of Medicine|August 22, 2019
Effects of Serelaxin in Patients with Acute Heart FailureMarco Metra, John R Teerlink, Gad Cotter, et al.
Pageof 46